Global Cell Lysis & Disruption Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 99833
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Cell Lysis & Disruption market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Cell Lysis & Disruption market size is estimated to be worth US$ 94 million in 2021 and is forecast to a readjusted size of USD 129.3 million by 2028 with a CAGR of 4.7% during review period. Protein Isolation accounting for % of the Cell Lysis & Disruption global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Mammalian cells segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Cell Lysis & Disruption include Thermo Fisher Scientific, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Qiagen NV, and Becton Dickinson & Company (BD), etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Cell Lysis & Disruption market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Mammalian cells

Bacterial cells

Yeast/Algae/Fungi

Plant cells

Market segment by Application, can be divided into

Protein Isolation

Downstream Processing

Cell Organelle Isolation

Nucleic Acid Isolation

Market segment by players, this report covers

Thermo Fisher Scientific, Inc.

Merck KGaA

F. Hoffmann-La Roche Ltd

Qiagen NV

Becton Dickinson & Company (BD)

Danaher Corporation

Bio-Rad Laboratories, Inc.

Miltenyi Biotec GmbH

Claremont BioSolutions, LLC

Microfluidics International Corporation

Parr Instrument Company

BioVision, Inc.

Covaris, Inc.

Qsonica LLC

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Cell Lysis & Disruption product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Cell Lysis & Disruption, with revenue, gross margin and global market share of Cell Lysis & Disruption from 2019 to 2022.

Chapter 3, the Cell Lysis & Disruption competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cell Lysis & Disruption market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Cell Lysis & Disruption research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Cell Lysis & Disruption

1.2 Classification of Cell Lysis & Disruption by Type

1.2.1 Overview: Global Cell Lysis & Disruption Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Cell Lysis & Disruption Revenue Market Share by Type in 2021

1.2.3 Mammalian cells

1.2.4 Bacterial cells

1.2.5 Yeast/Algae/Fungi

1.2.6 Plant cells

1.3 Global Cell Lysis & Disruption Market by Application

1.3.1 Overview: Global Cell Lysis & Disruption Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Protein Isolation

1.3.3 Downstream Processing

1.3.4 Cell Organelle Isolation

1.3.5 Nucleic Acid Isolation

1.4 Global Cell Lysis & Disruption Market Size & Forecast

1.5 Global Cell Lysis & Disruption Market Size and Forecast by Region

1.5.1 Global Cell Lysis & Disruption Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Cell Lysis & Disruption Market Size by Region, (2017-2022)

1.5.3 North America Cell Lysis & Disruption Market Size and Prospect (2017-2028)

1.5.4 Europe Cell Lysis & Disruption Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Cell Lysis & Disruption Market Size and Prospect (2017-2028)

1.5.6 South America Cell Lysis & Disruption Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Cell Lysis & Disruption Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Cell Lysis & Disruption Market Drivers

1.6.2 Cell Lysis & Disruption Market Restraints

1.6.3 Cell Lysis & Disruption Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Thermo Fisher Scientific, Inc.

2.1.1 Thermo Fisher Scientific, Inc. Details

2.1.2 Thermo Fisher Scientific, Inc. Major Business

2.1.3 Thermo Fisher Scientific, Inc. Cell Lysis & Disruption Product and Solutions

2.1.4 Thermo Fisher Scientific, Inc. Cell Lysis & Disruption Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans

2.2 Merck KGaA

2.2.1 Merck KGaA Details

2.2.2 Merck KGaA Major Business

2.2.3 Merck KGaA Cell Lysis & Disruption Product and Solutions

2.2.4 Merck KGaA Cell Lysis & Disruption Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Merck KGaA Recent Developments and Future Plans

2.3 F. Hoffmann-La Roche Ltd

2.3.1 F. Hoffmann-La Roche Ltd Details

2.3.2 F. Hoffmann-La Roche Ltd Major Business

2.3.3 F. Hoffmann-La Roche Ltd Cell Lysis & Disruption Product and Solutions

2.3.4 F. Hoffmann-La Roche Ltd Cell Lysis & Disruption Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans

2.4 Qiagen NV

2.4.1 Qiagen NV Details

2.4.2 Qiagen NV Major Business

2.4.3 Qiagen NV Cell Lysis & Disruption Product and Solutions

2.4.4 Qiagen NV Cell Lysis & Disruption Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Qiagen NV Recent Developments and Future Plans

2.5 Becton Dickinson & Company (BD)

2.5.1 Becton Dickinson & Company (BD) Details

2.5.2 Becton Dickinson & Company (BD) Major Business

2.5.3 Becton Dickinson & Company (BD) Cell Lysis & Disruption Product and Solutions

2.5.4 Becton Dickinson & Company (BD) Cell Lysis & Disruption Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Becton Dickinson & Company (BD) Recent Developments and Future Plans

2.6 Danaher Corporation

2.6.1 Danaher Corporation Details

2.6.2 Danaher Corporation Major Business

2.6.3 Danaher Corporation Cell Lysis & Disruption Product and Solutions

2.6.4 Danaher Corporation Cell Lysis & Disruption Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Danaher Corporation Recent Developments and Future Plans

2.7 Bio-Rad Laboratories, Inc.

2.7.1 Bio-Rad Laboratories, Inc. Details

2.7.2 Bio-Rad Laboratories, Inc. Major Business

2.7.3 Bio-Rad Laboratories, Inc. Cell Lysis & Disruption Product and Solutions

2.7.4 Bio-Rad Laboratories, Inc. Cell Lysis & Disruption Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans

2.8 Miltenyi Biotec GmbH

2.8.1 Miltenyi Biotec GmbH Details

2.8.2 Miltenyi Biotec GmbH Major Business

2.8.3 Miltenyi Biotec GmbH Cell Lysis & Disruption Product and Solutions

2.8.4 Miltenyi Biotec GmbH Cell Lysis & Disruption Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Miltenyi Biotec GmbH Recent Developments and Future Plans

2.9 Claremont BioSolutions, LLC

2.9.1 Claremont BioSolutions, LLC Details

2.9.2 Claremont BioSolutions, LLC Major Business

2.9.3 Claremont BioSolutions, LLC Cell Lysis & Disruption Product and Solutions

2.9.4 Claremont BioSolutions, LLC Cell Lysis & Disruption Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Claremont BioSolutions, LLC Recent Developments and Future Plans

2.10 Microfluidics International Corporation

2.10.1 Microfluidics International Corporation Details

2.10.2 Microfluidics International Corporation Major Business

2.10.3 Microfluidics International Corporation Cell Lysis & Disruption Product and Solutions

2.10.4 Microfluidics International Corporation Cell Lysis & Disruption Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Microfluidics International Corporation Recent Developments and Future Plans

2.11 Parr Instrument Company

2.11.1 Parr Instrument Company Details

2.11.2 Parr Instrument Company Major Business

2.11.3 Parr Instrument Company Cell Lysis & Disruption Product and Solutions

2.11.4 Parr Instrument Company Cell Lysis & Disruption Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Parr Instrument Company Recent Developments and Future Plans

2.12 BioVision, Inc.

2.12.1 BioVision, Inc. Details

2.12.2 BioVision, Inc. Major Business

2.12.3 BioVision, Inc. Cell Lysis & Disruption Product and Solutions

2.12.4 BioVision, Inc. Cell Lysis & Disruption Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 BioVision, Inc. Recent Developments and Future Plans

2.13 Covaris, Inc.

2.13.1 Covaris, Inc. Details

2.13.2 Covaris, Inc. Major Business

2.13.3 Covaris, Inc. Cell Lysis & Disruption Product and Solutions

2.13.4 Covaris, Inc. Cell Lysis & Disruption Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Covaris, Inc. Recent Developments and Future Plans

2.14 Qsonica LLC

2.14.1 Qsonica LLC Details

2.14.2 Qsonica LLC Major Business

2.14.3 Qsonica LLC Cell Lysis & Disruption Product and Solutions

2.14.4 Qsonica LLC Cell Lysis & Disruption Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Qsonica LLC Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Cell Lysis & Disruption Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Cell Lysis & Disruption Players Market Share in 2021

3.2.2 Top 10 Cell Lysis & Disruption Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Cell Lysis & Disruption Players Head Office, Products and Services Provided

3.4 Cell Lysis & Disruption Mergers & Acquisitions

3.5 Cell Lysis & Disruption New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Cell Lysis & Disruption Revenue and Market Share by Type (2017-2022)

4.2 Global Cell Lysis & Disruption Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Cell Lysis & Disruption Revenue Market Share by Application (2017-2022)

5.2 Global Cell Lysis & Disruption Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Cell Lysis & Disruption Revenue by Type (2017-2028)

6.2 North America Cell Lysis & Disruption Revenue by Application (2017-2028)

6.3 North America Cell Lysis & Disruption Market Size by Country

6.3.1 North America Cell Lysis & Disruption Revenue by Country (2017-2028)

6.3.2 United States Cell Lysis & Disruption Market Size and Forecast (2017-2028)

6.3.3 Canada Cell Lysis & Disruption Market Size and Forecast (2017-2028)

6.3.4 Mexico Cell Lysis & Disruption Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Cell Lysis & Disruption Revenue by Type (2017-2028)

7.2 Europe Cell Lysis & Disruption Revenue by Application (2017-2028)

7.3 Europe Cell Lysis & Disruption Market Size by Country

7.3.1 Europe Cell Lysis & Disruption Revenue by Country (2017-2028)

7.3.2 Germany Cell Lysis & Disruption Market Size and Forecast (2017-2028)

7.3.3 France Cell Lysis & Disruption Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Cell Lysis & Disruption Market Size and Forecast (2017-2028)

7.3.5 Russia Cell Lysis & Disruption Market Size and Forecast (2017-2028)

7.3.6 Italy Cell Lysis & Disruption Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Cell Lysis & Disruption Revenue by Type (2017-2028)

8.2 Asia-Pacific Cell Lysis & Disruption Revenue by Application (2017-2028)

8.3 Asia-Pacific Cell Lysis & Disruption Market Size by Region

8.3.1 Asia-Pacific Cell Lysis & Disruption Revenue by Region (2017-2028)

8.3.2 China Cell Lysis & Disruption Market Size and Forecast (2017-2028)

8.3.3 Japan Cell Lysis & Disruption Market Size and Forecast (2017-2028)

8.3.4 South Korea Cell Lysis & Disruption Market Size and Forecast (2017-2028)

8.3.5 India Cell Lysis & Disruption Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Cell Lysis & Disruption Market Size and Forecast (2017-2028)

8.3.7 Australia Cell Lysis & Disruption Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Cell Lysis & Disruption Revenue by Type (2017-2028)

9.2 South America Cell Lysis & Disruption Revenue by Application (2017-2028)

9.3 South America Cell Lysis & Disruption Market Size by Country

9.3.1 South America Cell Lysis & Disruption Revenue by Country (2017-2028)

9.3.2 Brazil Cell Lysis & Disruption Market Size and Forecast (2017-2028)

9.3.3 Argentina Cell Lysis & Disruption Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Cell Lysis & Disruption Revenue by Type (2017-2028)

10.2 Middle East & Africa Cell Lysis & Disruption Revenue by Application (2017-2028)

10.3 Middle East & Africa Cell Lysis & Disruption Market Size by Country

10.3.1 Middle East & Africa Cell Lysis & Disruption Revenue by Country (2017-2028)

10.3.2 Turkey Cell Lysis & Disruption Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Cell Lysis & Disruption Market Size and Forecast (2017-2028)

10.3.4 UAE Cell Lysis & Disruption Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Cell Lysis & Disruption Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Cell Lysis & Disruption Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Cell Lysis & Disruption Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Cell Lysis & Disruption Revenue (USD Million) by Region (2017-2022)

Table 5. Global Cell Lysis & Disruption Revenue Market Share by Region (2023-2028)

Table 6. Thermo Fisher Scientific, Inc. Corporate Information, Head Office, and Major Competitors

Table 7. Thermo Fisher Scientific, Inc. Major Business

Table 8. Thermo Fisher Scientific, Inc. Cell Lysis & Disruption Product and Solutions

Table 9. Thermo Fisher Scientific, Inc. Cell Lysis & Disruption Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Merck KGaA Corporate Information, Head Office, and Major Competitors

Table 11. Merck KGaA Major Business

Table 12. Merck KGaA Cell Lysis & Disruption Product and Solutions

Table 13. Merck KGaA Cell Lysis & Disruption Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. F. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors

Table 15. F. Hoffmann-La Roche Ltd Major Business

Table 16. F. Hoffmann-La Roche Ltd Cell Lysis & Disruption Product and Solutions

Table 17. F. Hoffmann-La Roche Ltd Cell Lysis & Disruption Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Qiagen NV Corporate Information, Head Office, and Major Competitors

Table 19. Qiagen NV Major Business

Table 20. Qiagen NV Cell Lysis & Disruption Product and Solutions

Table 21. Qiagen NV Cell Lysis & Disruption Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Becton Dickinson & Company (BD) Corporate Information, Head Office, and Major Competitors

Table 23. Becton Dickinson & Company (BD) Major Business

Table 24. Becton Dickinson & Company (BD) Cell Lysis & Disruption Product and Solutions

Table 25. Becton Dickinson & Company (BD) Cell Lysis & Disruption Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Danaher Corporation Corporate Information, Head Office, and Major Competitors

Table 27. Danaher Corporation Major Business

Table 28. Danaher Corporation Cell Lysis & Disruption Product and Solutions

Table 29. Danaher Corporation Cell Lysis & Disruption Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Bio-Rad Laboratories, Inc. Corporate Information, Head Office, and Major Competitors

Table 31. Bio-Rad Laboratories, Inc. Major Business

Table 32. Bio-Rad Laboratories, Inc. Cell Lysis & Disruption Product and Solutions

Table 33. Bio-Rad Laboratories, Inc. Cell Lysis & Disruption Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Miltenyi Biotec GmbH Corporate Information, Head Office, and Major Competitors

Table 35. Miltenyi Biotec GmbH Major Business

Table 36. Miltenyi Biotec GmbH Cell Lysis & Disruption Product and Solutions

Table 37. Miltenyi Biotec GmbH Cell Lysis & Disruption Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Claremont BioSolutions, LLC Corporate Information, Head Office, and Major Competitors

Table 39. Claremont BioSolutions, LLC Major Business

Table 40. Claremont BioSolutions, LLC Cell Lysis & Disruption Product and Solutions

Table 41. Claremont BioSolutions, LLC Cell Lysis & Disruption Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Microfluidics International Corporation Corporate Information, Head Office, and Major Competitors

Table 43. Microfluidics International Corporation Major Business

Table 44. Microfluidics International Corporation Cell Lysis & Disruption Product and Solutions

Table 45. Microfluidics International Corporation Cell Lysis & Disruption Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Parr Instrument Company Corporate Information, Head Office, and Major Competitors

Table 47. Parr Instrument Company Major Business

Table 48. Parr Instrument Company Cell Lysis & Disruption Product and Solutions

Table 49. Parr Instrument Company Cell Lysis & Disruption Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. BioVision, Inc. Corporate Information, Head Office, and Major Competitors

Table 51. BioVision, Inc. Major Business

Table 52. BioVision, Inc. Cell Lysis & Disruption Product and Solutions

Table 53. BioVision, Inc. Cell Lysis & Disruption Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Covaris, Inc. Corporate Information, Head Office, and Major Competitors

Table 55. Covaris, Inc. Major Business

Table 56. Covaris, Inc. Cell Lysis & Disruption Product and Solutions

Table 57. Covaris, Inc. Cell Lysis & Disruption Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Qsonica LLC Corporate Information, Head Office, and Major Competitors

Table 59. Qsonica LLC Major Business

Table 60. Qsonica LLC Cell Lysis & Disruption Product and Solutions

Table 61. Qsonica LLC Cell Lysis & Disruption Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Global Cell Lysis & Disruption Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 63. Global Cell Lysis & Disruption Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 64. Breakdown of Cell Lysis & Disruption by Company Type (Tier 1, Tier 2 and Tier 3)

Table 65. Cell Lysis & Disruption Players Head Office, Products and Services Provided

Table 66. Cell Lysis & Disruption Mergers & Acquisitions in the Past Five Years

Table 67. Cell Lysis & Disruption New Entrants and Expansion Plans

Table 68. Global Cell Lysis & Disruption Revenue (USD Million) by Type (2017-2022)

Table 69. Global Cell Lysis & Disruption Revenue Share by Type (2017-2022)

Table 70. Global Cell Lysis & Disruption Revenue Forecast by Type (2023-2028)

Table 71. Global Cell Lysis & Disruption Revenue by Application (2017-2022)

Table 72. Global Cell Lysis & Disruption Revenue Forecast by Application (2023-2028)

Table 73. North America Cell Lysis & Disruption Revenue by Type (2017-2022) & (USD Million)

Table 74. North America Cell Lysis & Disruption Revenue by Type (2023-2028) & (USD Million)

Table 75. North America Cell Lysis & Disruption Revenue by Application (2017-2022) & (USD Million)

Table 76. North America Cell Lysis & Disruption Revenue by Application (2023-2028) & (USD Million)

Table 77. North America Cell Lysis & Disruption Revenue by Country (2017-2022) & (USD Million)

Table 78. North America Cell Lysis & Disruption Revenue by Country (2023-2028) & (USD Million)

Table 79. Europe Cell Lysis & Disruption Revenue by Type (2017-2022) & (USD Million)

Table 80. Europe Cell Lysis & Disruption Revenue by Type (2023-2028) & (USD Million)

Table 81. Europe Cell Lysis & Disruption Revenue by Application (2017-2022) & (USD Million)

Table 82. Europe Cell Lysis & Disruption Revenue by Application (2023-2028) & (USD Million)

Table 83. Europe Cell Lysis & Disruption Revenue by Country (2017-2022) & (USD Million)

Table 84. Europe Cell Lysis & Disruption Revenue by Country (2023-2028) & (USD Million)

Table 85. Asia-Pacific Cell Lysis & Disruption Revenue by Type (2017-2022) & (USD Million)

Table 86. Asia-Pacific Cell Lysis & Disruption Revenue by Type (2023-2028) & (USD Million)

Table 87. Asia-Pacific Cell Lysis & Disruption Revenue by Application (2017-2022) & (USD Million)

Table 88. Asia-Pacific Cell Lysis & Disruption Revenue by Application (2023-2028) & (USD Million)

Table 89. Asia-Pacific Cell Lysis & Disruption Revenue by Region (2017-2022) & (USD Million)

Table 90. Asia-Pacific Cell Lysis & Disruption Revenue by Region (2023-2028) & (USD Million)

Table 91. South America Cell Lysis & Disruption Revenue by Type (2017-2022) & (USD Million)

Table 92. South America Cell Lysis & Disruption Revenue by Type (2023-2028) & (USD Million)

Table 93. South America Cell Lysis & Disruption Revenue by Application (2017-2022) & (USD Million)

Table 94. South America Cell Lysis & Disruption Revenue by Application (2023-2028) & (USD Million)

Table 95. South America Cell Lysis & Disruption Revenue by Country (2017-2022) & (USD Million)

Table 96. South America Cell Lysis & Disruption Revenue by Country (2023-2028) & (USD Million)

Table 97. Middle East & Africa Cell Lysis & Disruption Revenue by Type (2017-2022) & (USD Million)

Table 98. Middle East & Africa Cell Lysis & Disruption Revenue by Type (2023-2028) & (USD Million)

Table 99. Middle East & Africa Cell Lysis & Disruption Revenue by Application (2017-2022) & (USD Million)

Table 100. Middle East & Africa Cell Lysis & Disruption Revenue by Application (2023-2028) & (USD Million)

Table 101. Middle East & Africa Cell Lysis & Disruption Revenue by Country (2017-2022) & (USD Million)

Table 102. Middle East & Africa Cell Lysis & Disruption Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Cell Lysis & Disruption Picture

Figure 2. Global Cell Lysis & Disruption Revenue Market Share by Type in 2021

Figure 3. Mammalian cells

Figure 4. Bacterial cells

Figure 5. Yeast/Algae/Fungi

Figure 6. Plant cells

Figure 7. Cell Lysis & Disruption Revenue Market Share by Application in 2021

Figure 8. Protein Isolation Picture

Figure 9. Downstream Processing Picture

Figure 10. Cell Organelle Isolation Picture

Figure 11. Nucleic Acid Isolation Picture

Figure 12. Global Cell Lysis & Disruption Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Cell Lysis & Disruption Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Cell Lysis & Disruption Revenue Market Share by Region (2017-2028)

Figure 15. Global Cell Lysis & Disruption Revenue Market Share by Region in 2021

Figure 16. North America Cell Lysis & Disruption Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Cell Lysis & Disruption Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Cell Lysis & Disruption Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Cell Lysis & Disruption Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Cell Lysis & Disruption Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Cell Lysis & Disruption Market Drivers

Figure 22. Cell Lysis & Disruption Market Restraints

Figure 23. Cell Lysis & Disruption Market Trends

Figure 24. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans

Figure 25. Merck KGaA Recent Developments and Future Plans

Figure 26. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans

Figure 27. Qiagen NV Recent Developments and Future Plans

Figure 28. Becton Dickinson & Company (BD) Recent Developments and Future Plans

Figure 29. Danaher Corporation Recent Developments and Future Plans

Figure 30. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans

Figure 31. Miltenyi Biotec GmbH Recent Developments and Future Plans

Figure 32. Claremont BioSolutions, LLC Recent Developments and Future Plans

Figure 33. Microfluidics International Corporation Recent Developments and Future Plans

Figure 34. Parr Instrument Company Recent Developments and Future Plans

Figure 35. BioVision, Inc. Recent Developments and Future Plans

Figure 36. Covaris, Inc. Recent Developments and Future Plans

Figure 37. Qsonica LLC Recent Developments and Future Plans

Figure 38. Global Cell Lysis & Disruption Revenue Share by Players in 2021

Figure 39. Cell Lysis & Disruption Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 40. Global Top 3 Players Cell Lysis & Disruption Revenue Market Share in 2021

Figure 41. Global Top 10 Players Cell Lysis & Disruption Revenue Market Share in 2021

Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 43. Global Cell Lysis & Disruption Revenue Share by Type in 2021

Figure 44. Global Cell Lysis & Disruption Market Share Forecast by Type (2023-2028)

Figure 45. Global Cell Lysis & Disruption Revenue Share by Application in 2021

Figure 46. Global Cell Lysis & Disruption Market Share Forecast by Application (2023-2028)

Figure 47. North America Cell Lysis & Disruption Sales Market Share by Type (2017-2028)

Figure 48. North America Cell Lysis & Disruption Sales Market Share by Application (2017-2028)

Figure 49. North America Cell Lysis & Disruption Revenue Market Share by Country (2017-2028)

Figure 50. United States Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Canada Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Mexico Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Europe Cell Lysis & Disruption Sales Market Share by Type (2017-2028)

Figure 54. Europe Cell Lysis & Disruption Sales Market Share by Application (2017-2028)

Figure 55. Europe Cell Lysis & Disruption Revenue Market Share by Country (2017-2028)

Figure 56. Germany Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. France Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. United Kingdom Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Russia Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Italy Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Asia-Pacific Cell Lysis & Disruption Sales Market Share by Type (2017-2028)

Figure 62. Asia-Pacific Cell Lysis & Disruption Sales Market Share by Application (2017-2028)

Figure 63. Asia-Pacific Cell Lysis & Disruption Revenue Market Share by Region (2017-2028)

Figure 64. China Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Japan Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South Korea Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. India Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Southeast Asia Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Australia Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. South America Cell Lysis & Disruption Sales Market Share by Type (2017-2028)

Figure 71. South America Cell Lysis & Disruption Sales Market Share by Application (2017-2028)

Figure 72. South America Cell Lysis & Disruption Revenue Market Share by Country (2017-2028)

Figure 73. Brazil Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Argentina Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Middle East and Africa Cell Lysis & Disruption Sales Market Share by Type (2017-2028)

Figure 76. Middle East and Africa Cell Lysis & Disruption Sales Market Share by Application (2017-2028)

Figure 77. Middle East and Africa Cell Lysis & Disruption Revenue Market Share by Country (2017-2028)

Figure 78. Turkey Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Saudi Arabia Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. UAE Cell Lysis & Disruption Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Methodology

Figure 82. Research Process and Data Source